SCHEMBL31107270

SCHEMBL31107270

CC(C)(C)OC(=O)N1CCN2Cc3cc(Cl)c(-c4c(O)cccc4Cl)c(F)c3OC[C@H]2C1

nearest known ligand 0.73

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KRAS P01116 20/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24558257 1.00 KRAS (0.73) KRAS
SCHEMBL24558281 0.94 KRAS (0.74) KRAS
SCHEMBL29693169 0.94 KRAS (0.74) KRAS
SCHEMBL24558210 0.91 KRAS (0.67) KRAS
SCHEMBL29693208 0.90 KRAS (0.77) KRAS
SCHEMBL29693144 0.90 KRAS (0.77) KRAS
SCHEMBL24558336 0.90 KRAS (0.77) KRAS
SCHEMBL24558359 0.90 KRAS (0.77) KRAS
SCHEMBL24558376 0.89 KRAS (0.67) KRAS
SCHEMBL29693113 0.89 KRAS (0.67) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508118-B Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2024-07-19 CN disclosed